White House Holds Summit on Addiction Care for Homeless
ONDCP, SAMHSA, and HUD launch two-day summit to develop national toolkit for treating substance use disorders among homeless populations.
April 15, 20266 min read
Blog & News
Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
AllTreatment AccessOpioid CrisisFederal Policytreatment-accessClinical ResearchHarm ReductionSubstance Use DisorderOpioid AddictionMental HealthState LegislationMedication-Assisted Treatmentopioid-crisisclinical-researchfederal-policyData ReportsFundingopioid-addictionsubstance-use-disordermedication-assisted-treatmentmental-healthdata-reportsharm-reductionstate-legislationPsychedelicsClinical TrialsfundingAlcohol Addictionclinical-trialsbehavioral-therapyBuprenorphinepsychedelicsbuprenorphineBehavioral Therapydigital-healthalcohol-addictionGambling AddictionStimulant AddictionTelehealthtelehealthDigital HealthPeer RecoveryComplementary TherapyMedication Assisted Treatmentrural-healthcareSubstance-Use-DisorderSynthetic Opioidsgambling-addictionYouthFentanylMarijuana Dependenceadolescent-healthmarijuana-dependencepeer-recoveryyouthmobile-healthstimulant-addictionFederal-PolicyClinical-TrialsClinical-ResearchLitigationInternationalTreatment OptionsRecoveryRehabilitationResearch
Synthetic Opioid Cychlorphine Spreads, Resists Naloxone
Drug 5-10 times more potent than fentanyl detected in Georgia and Missouri, as new study reveals standard naloxone doses may be insufficient for reversing synthetic opioid overdoses.
April 14, 20268 min read
Cytisinicline Nears FDA Nod as First New Smoking Cessation Drug
With PDUFA date set for June 20, 2026, cytisinicline could become the first novel smoking cessation pharmacotherapy approved by FDA in nearly 20 years.
April 14, 20265 min read
FDA MDMA Rejection Triggers Psychedelic Industry Reset
Lykos Therapeutics slashes workforce by 75% after Complete Response Letter reveals FDA concerns about trial design and durability, forcing psychedelic research firms to reconsider regulatory strategy.
April 14, 20267 min read
Iowa Opens $10M Opioid Crisis Round From Settlement Funds
Iowa launches competitive grant program directing 75% of opioid settlement funds toward prevention, treatment, and recovery services across the state.
April 14, 20264 min read
Mirtazapine Cuts Meth Use in Australian Phase 3 Tina Trial
Phase 3 study of 339 adults finds cheap, widely available medication cuts meth use by seven days per month, offering first pharmacological treatment option for stimulant use disorder.
April 13, 20267 min read
Wisconsin Allocates $31M in Opioid Settlement to Tribes, Care
State health officials announce two-year spending plan prioritizing disproportionately impacted populations, room and board assistance for residential treatment, and naloxone distribution as overdose deaths decline 42.5%.
April 10, 202610 min read
CDC Warns 'Rhino Tranq' Fentanyl Resists Naloxone
Federal health officials alert providers to medetomidine, a potent animal sedative spreading through the illegal opioid supply, causing naloxone-resistant overdoses and life-threatening withdrawal.
April 9, 20268 min read
NIH Engineers DFNZ: Pain Relief Without Addiction Risk
National Institute on Drug Abuse researchers transform a dangerous synthetic opioid class into a potential therapeutic, creating a compound that relieves pain without causing tolerance, dependence, or fatal overdose risk.
April 9, 20268 min read